Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.

Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, Williams PM, Modrusan Z, Feuerstein BG, Aldape K.

Cancer Cell. 2006 Mar;9(3):157-73.

2.

IDH mutation and neuroglial developmental features define clinically distinct subclasses of lower grade diffuse astrocytic glioma.

Gorovets D, Kannan K, Shen R, Kastenhuber ER, Islamdoust N, Campos C, Pentsova E, Heguy A, Jhanwar SC, Mellinghoff IK, Chan TA, Huse JT.

Clin Cancer Res. 2012 May 1;18(9):2490-501. doi: 10.1158/1078-0432.CCR-11-2977. Epub 2012 Mar 13.

3.

Molecular voting for glioma classification reflecting heterogeneity in the continuum of cancer progression.

Fuller GN, Mircean C, Tabus I, Taylor E, Sawaya R, Bruner JM, Shmulevich I, Zhang W.

Oncol Rep. 2005 Sep;14(3):651-6.

PMID:
16077969
4.

Gene expression profiling of gliomas strongly predicts survival.

Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, Liau LM, Mischel PS, Nelson SF.

Cancer Res. 2004 Sep 15;64(18):6503-10.

5.

Gliomas: advances in molecular analysis and characterization.

Boudreau CR, Yang I, Liau LM.

Surg Neurol. 2005 Oct;64(4):286-94; discussion 294. Review.

PMID:
16229087
6.

Expression of multiple larger-sized transcripts for several genes in oligodendrogliomas: potential markers for glioma subtype.

Xu X, Joh HD, Pin S, Schiller NI, Prange C, Burger PC, Schiller MR.

Cancer Lett. 2001 Sep 28;171(1):67-77.

PMID:
11485829
8.

Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.

Pollack IF, Hamilton RL, James CD, Finkelstein SD, Burnham J, Yates AJ, Holmes EJ, Zhou T, Finlay JL; Children's Oncology Group.

J Neurosurg. 2006 Nov;105(5 Suppl):418-24.

PMID:
17328268
9.

Glioma cells on the run - the migratory transcriptome of 10 human glioma cell lines.

Demuth T, Rennert JL, Hoelzinger DB, Reavie LB, Nakada M, Beaudry C, Nakada S, Anderson EM, Henrichs AN, McDonough WS, Holz D, Joy A, Lin R, Pan KH, Lih CJ, Cohen SN, Berens ME.

BMC Genomics. 2008 Jan 29;9:54. doi: 10.1186/1471-2164-9-54.

10.

Genetic characterization of commonly used glioma cell lines in the rat animal model system.

Sibenaller ZA, Etame AB, Ali MM, Barua M, Braun TA, Casavant TL, Ryken TC.

Neurosurg Focus. 2005 Oct 15;19(4):E1.

PMID:
16241103
11.

Toward a molecular classification of the gliomas: histopathology, molecular genetics, and gene expression profiling.

Caskey LS, Fuller GN, Bruner JM, Yung WK, Sawaya RE, Holland EC, Zhang W.

Histol Histopathol. 2000 Jul;15(3):971-81. Review.

PMID:
10963139
12.

Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.

Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR, Louis DN.

Cancer Res. 2003 Apr 1;63(7):1602-7.

13.

Outcome-based profiling of astrocytic tumours identifies prognostic gene expression signatures which link molecular and morphology-based pathology.

Beetz C, Bergner S, Brodoehl S, Brodhun M, Ewald C, Kalff R, Krüger J, Patt S, Kiehntopf M, Deufel T.

Int J Oncol. 2006 Nov;29(5):1183-91.

PMID:
17016650
14.

Coexpression network analysis identifies transcriptional modules related to proastrocytic differentiation and sprouty signaling in glioma.

Ivliev AE, 't Hoen PA, Sergeeva MG.

Cancer Res. 2010 Dec 15;70(24):10060-70. doi: 10.1158/0008-5472.CAN-10-2465.

15.

Using gene expression profiling to identify a prognostic molecular spectrum in gliomas.

Shirahata M, Oba S, Iwao-Koizumi K, Saito S, Ueno N, Oda M, Hashimoto N, Ishii S, Takahashi JA, Kato K.

Cancer Sci. 2009 Jan;100(1):165-72. doi: 10.1111/j.1349-7006.2008.01002.x. Epub 2008 Nov 24.

16.

DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH.

Kresse SH, Skårn M, Ohnstad HO, Namløs HM, Bjerkehagen B, Myklebost O, Meza-Zepeda LA.

Mol Cancer. 2008 Jun 3;7:48. doi: 10.1186/1476-4598-7-48.

17.

Gene expression profile as a prognostic factor in high-grade gliomas.

Czernicki T, Zegarska J, Paczek L, Cukrowska B, Grajkowska W, Zajaczkowska A, Brudzewski K, Ulaczyk J, Marchel A.

Int J Oncol. 2007 Jan;30(1):55-64.

PMID:
17143512
18.
19.

Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma.

Chua MS, Sun H, Cheung ST, Mason V, Higgins J, Ross DT, Fan ST, So S.

Mod Pathol. 2007 Jan;20(1):76-83. Epub 2006 Sep 29.

20.

Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.

Gravendeel LA, Kouwenhoven MC, Gevaert O, de Rooi JJ, Stubbs AP, Duijm JE, Daemen A, Bleeker FE, Bralten LB, Kloosterhof NK, De Moor B, Eilers PH, van der Spek PJ, Kros JM, Sillevis Smitt PA, van den Bent MJ, French PJ.

Cancer Res. 2009 Dec 1;69(23):9065-72. doi: 10.1158/0008-5472.CAN-09-2307. Epub 2009 Nov 17.

Supplemental Content

Support Center